12:00 AM
 | 
Oct 08, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Amarantus BioSciences preclinical data

In a mouse model of MI, MANF reduced infarct zone size by about 44% vs. placebo. Data were...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >